and -positive bacteria and have been used in both veterinary as well as human medical applications. In the United States, FQs are no longer approved for use in chickens due to concerns about an observed increase in microbial resistance. The European Union (EU) allows use of several FQs in poultry, with maximum residue levels (MRL) ranging from 100-400 ng/g in muscle or 100-1900 ng/g in liver (1) . Whether banned or allowed with an MRL, it is important to monitor the food supply for FQ residues.
Multiresidue methods for determination of FQs in chicken muscle have been recently developed (2-7) in order to provide increased efficiency over methods designed for I or 2 FQs. Muscle can be a difficult matrix to work with, however, as it requires physical homogenization to ensure efficient extraction of FQs. In the United States, the ban on FQ use in chickens means that analyses no longer need be limited to muscle, the former target tissue. A finding of FQs in any chicken matrix would constitute a violation. Chicken blood (whole, plasma, or serum) would appear to be an easier matrix to monitor because, being liquid, it could be easier to extract. As a further benefit, blood is a less expensive sample material for monitoring than chicken breast. A number of methods have been devised for determination of EQs in blood, although most of these address only [1] [2] [3] FQs. Several methods for determination of 4 or more FQs from blood have been reported (8) (9) (10) (11) (12) , which rely on liquid chromatography (LC) or capillary electrophoresis with either UV or fluorescence detection. One of these reports determination of 5 FQs from chicken blood (9) . None of the above reports describes the use of mass spectrometry (MS), a technique that has been relied upon increasingly to provide confirmation in residue analysis.
The goal of this work was to evaluate serum as a matrix for multiresidue analysis of FQs in chicken, using the highly efficient LC-fluorescence-MS" (multiple mass spectrometry) approach developed previously for muscle (4) . This approach would allow for simultaneous quantitation (fluorescence) and confirmation (MS"). All matrixes do not necessarily work equally well with a given analytical approach, and we judged it important to test serum as a matrix that, if successful, could provide a much easier and efficient route to analysis of FQs in N(a(a(N(N(a(N(N(NQ(N(aC) N-(a (a (a (a N-N-N-(a N-(a (a N-(a (C (a (a N-N chicken than those currently available. In addition, we sought to undertake a preliminary comparison of muscle and serum enrofloxacin (ENRO) levels in the same ENRO-dosed birds.
Experimental

Apparatus
(a) LC-fluorescence-MS" system .-Hewlett-Packard (Wilmington, DE) 1100 binary LC pump with online degasser, autosampler, column heater, and fluorescence detector, connected to a ThermoQuest (San Jose, CA) LCQ-Deca mass spectrometer". Xcalibur software version 1.2 was used to process data from the fluorescence detector via an SS-420 X module (Scientific Software, Pleasanton, CA) and controlled all other LC and mass spectrometer functions. The sample injection volume was 40 )sL.
( 
Control Chicken Muscle and Serum
Control chicken breast muscle samples (Bell and Evans, Fredericksburg, PA) were purchased from a local grocery. The muscle was cut into small pieces and homogenized with a food processor. The homogenized muscle samples were stored at -80°C. Fresh control chicken blood was obtained from a local poultry processing plant. It was centrifuged at 1500 x g for 20 mm, and the resultant serum layer was decanted into disposable centrifuge tubes and stored at -80°C.
ENRO-Incurred Chicken Muscle and Serum
Broiler chickens were obtained from a local hatchery and housed at the University of Arkansas Poultry Farm. All birds initially had ad libitum access to a standard nonmedicated broiler diet and water. Starting at 4 weeks of age, birds were dosed for 3 days in the drinking water with 50 jig/mL ENRO (Baytril Bayer), a dosing level approved by the U.S. Food and Drug Administration (FDA) prior to its prohibition for poultry. Medicated water was prepared fresh daily. Both blood and muscle samples were collected prior to dosing (controls); at the end of 1 and 3 days of dosing; and 12, 24, 36, and 48 h after ENRO withdrawal (n = 6 birds collected at each time).
Collected blood was allowed to clot for approximately 30 mm at room temperature and centrifuged for 20 min at 1500 x g, and the serum was decanted. All samples were stored at -80°C until shipped overnight on dry ice to the U.S. Department of Agriculture (USDA) facilities in Pennsylvania, where they were again stored at -80°C. Prior to analysis, incurred samples were pooled from each sampling time point, using an equal mass of muscle or serum from each bird. The pooling process was straightforward for thawed serum, but required an additional food processor treatment to achieve homogeneity with muscle samples. A single portion of each incurred sample was initially extracted and analyzed to determine the approximate ENRO concentrations. Incurred samples were then diluted with the corresponding control tissue or serum to ensure ENRO concentrations measured would fall within an optimum range (2-100 ng/g). Diluted samples were then mixed (serum) or homogenized with a food processor (muscle) prior to replicate extraction and analysis.
Fortification and Extraction of Chicken Serum and Muscle Samples
Serum samples (1.0 g) were placed in 15 mL disposable centrifuge tubes, and a portion of fortification solution (fortified samples) or 0.1 M phosphate buffer, pH 9.0 (control and incurred samples), was added. After mixing on a Vortex mixer, the samples were stored in reduced light at room temperature for 30 mm. Acetonitrile (3 ml-) and concentrated ammonium hydroxide (0.25 mL) were added to each tube. After mixing on a Vortex mixer (15 s), the samples were centrifuged (3061 x g) and the supernatants decanted into fresh 50 mL disposable centrifuge tubes. Diethyl ether (3 mL), hexane (3 mL), and I M NaCI (0.25 mL) were added to each sample, and the mixture was mixed on a Vortex mixer (15 s). The upper layer was then discarded, and the lower layers were transferred to a glass culture tube. These samples were then evaporated to dryness under a stream of nitrogen at 40°C, with occasional addition of acetonitrile (1 mL) to facilitate this process. The residue was dissolved in 0.1 M phosphate buffer, pH 9.0 (2.0 mL, except for the 48 h withdrawal sample, which used 1.0 mL to facilitate confirmation), and syringe filtered into an amber autosampler vial for analysis.
Muscle samples (1.0 g) were fortified and extracted as described previously (4) , except that pellets from the first extraction were reextracted once after addition of water (750 l.LL).
Liquid Chromatography-Fluorescence
A gradient with Solvent A (1% formic acid, pH 3, with ammonium hydroxide) and Solvent B (acetonitrile) was used as follows: 14% B (10 min), 14-20°/o B (8 mm), 20% B (2 mm), 20-80% B (2 mm), 80% B (2 mm), 80-14% B (3 mm), and 14% B (3 mm). The temperature of the column was maintained at 30°C, and the flow rate was 0.5 mL/min. A divert valve was used for the first 5 min and the last 7 min of the gradient to minimize phosphate and matrix components entering the mass spectrometer. Fluorescence detection used excitation wavelength (2,x) 275 nm and emission wavelength (2,m) 440 nm.
Mass Spectrometrj,I
The mass spectrometer was operated in positive ion atmospheric pressure chemical ionization (APCI) mode with a maximum injection time of 400 ms, automatic gain control, and ion targets for MS and MS of 5 x 107 and 2 x 10, respectively. FQ fragmentation patterns, tuning, and MS' parameters were determined while infusing a 10 .tg/InL solution of each FQ in mobile phase (5 Table 1 . All FQs used an RF fragmentation frequency (Q) value of 0.25, except for DCJP (Q = 0.3), which also used wide band activation. The scan range was 200-400 m/z, except for ORBI, SAR, and DIF, which were monitored to 450 mlz. Retention time windows were checked daily with a standard mixture of the 8 FQs and adjusted as needed.
Results and Discussion
A goal of this work was to determine if FQs could be extracted efficiently from chicken blood, either as plasma or serum. Collection of control chicken blood samples from a processing plant illustrated the rapidity with which the blood clotted. While the use of an anticoagulant such as ethylenediaminetetraacetic acid (EDTA) would make plasma collection possible, we elected to proceed with a study of serum, on the grounds that it would make any future sample collection simpler.
We began testing extraction of FQs from fortified serum using the basic approach reported previously for muscle (4) . We quickly found that serum was, indeed, a much easier matrix to work with than muscle, as all extractions could be performed rapidly with a Vortex mixer, rather than requiring use of a homogenizer. It was easily possible in 1 day to extract 15 serum samples, along with the required controls, rather than the usual 10 muscle samples and controls. The result was that the rate limiting step for analysis of serum samples shifted from sample extraction to the step involving duplicate injections on the LC-fluorescence-MS system. As the latter system can run unattended, this represents considerable saving of time and effort. In examining the extraction method for FQ fortified serum, the use of 1% acetic acid in acetonitrile as an extraction solvent was investigated. This approach produced lower FQ recoveries, particularly for DCIP (69 versus 83% in the experiment), and work proceeded with ammoniacal acetonitrile as the extraction solvent.
The effect of a defatting step in the procedure was studied. An extraction with ether-hexane-NaC1 did not lead to significantly different FQ recoveries (88-97 versus 91-96% for the cleanup experiment), and it did appear to remove some extraneous material, so the step was included in the method.
A further advantage of serum as a matrix was found when 1 extraction sufficed to produce excellent FQ recoveries, with no significant improvement after a second extraction. With muscle, 2 extractions are used to produce optimum recoveries, requiring significantly more time and effort.
A final advantage found in the serum extraction was that the evaporated residue could easily be dissolved in 1.0 mL phosphate buffer. In muscle, 2.0 mL buffer is used to resuspend the residue, which does not all dissolve prior to filtering. The advantage of using less volume at this stage is that the final sample will have a higher FQ concentration, which will produce a stronger MS signal and facilitate confirmation. This could potentially be very helpful for low-level FQ samples, and this approach was used for analysis of the ENRO-incurred 48 h withdrawal serum sample.
Extraction of FQs from muscle used essentially the method developed previously (4). Addition of a small portion of water to the first pellet before the second extraction had been found subsequently to improve recovery of the more polar FQs (13), and this approach was incorporated in this work.
In order to determine recoveries of the FQs, control chicken serum samples were fortified with a mixture of 8 FQs at levels of 10, 20, 50, and 100 ng/g, and then extracted. Five replicate extractions were conducted for each level on each of 3 different analysis days. For comparison purposes, samples of FQ-fortified chicken muscle were extracted as well. Sample chromatograms of serum extracts are provided in Figure 1 , illustrating the separation achieved for the 8 FQs and an ENRO-incurred extract, along with a control serum extract. FQ recoveries are reported in Table 2 . The results were very satisfactory, with individual recoveries ranging from 71-99% for serum and 68-90% for muscle. Calculated relative standard deviations (RSD5) for both intraday and interday variations were uniformly <10%. Recoveries in serum were generally slightly higher than in muscle, presumably due to the less involved extraction required.
Quantitation of FQs was achieved using an external standard curve generated daily using dilutions of the fortification solution and measurement of fluorescence peak height. Dilutions of standards were initially prepared in both 0.1 M phosphate buffer, pH 9.0, and matrix extract (matrix matched). A slight matrix enhancement effect was observed for serum in the MSn peak intensity, as had been noted previously for other matrixes (4, 13). As there was no significant difference in either recovery or confirmation results with matrix matched or buffer standards, standards diluted in buffer were used for the remainder of the experiments. Seven-point standard curves ran from 2-100 ng/mL and displayed excellent linearity (? ^! 0.999). An exception was DCIP, whose intense fluorescence response led to apparent saturation at 100 ng/ml. when 40 1.iL, rather than the formerly used 20 i.tL, samples were injected. DCIP thus relied on 6-point standard curves (2-75 ng/mL) for 40 iL injections, and, under these conditions, displayed excellent linearity.
Fluorescence limits of quantitation (LOQs) were determined as 10 times the root mean square of the noise divided by the slope of the standard curve. FQ LOQs in serum and muscle are listed in Table 3 . The use of fluorescence for quantitation of the FQs allows for these low LOQ values and ensures excellent sensitivity.
Confirmation of the FQs was achieved by examination of the peak height ratios of 2 major MS 2 (DCIP) or MS 3 (NOR, CIP, DANO, ENRO, ORBI, SAR, and DIF) product ions, and comparison to the corresponding ratios from standard samples. Table 1 shows peak ratio data for the serum and muscle samples described in Table 2 . Average peak ratios are reported, with n = 10 (5 replicate samples, each injected twice). Peak ratios are also reported in Table 1 for standard FQ samples in buffer, averaged over 12 different analysis days. Although some FQs generally gave peak ratios with excellent reproducibility at 2 ng/g levels, the variability typically increases with decreased concentration (4). Thus, peak ratios representing the range of 10-100 ng/g were chosen for the standards. Comparison of the fortified sample peak ratios with those of the standard FQ samples shows excellent agreement with, for the most part, excellent RSDs. Specifically, confirmation was judged to be successful if the average for the fortified samples was within 3 standard deviation (SD) intervals (99% probability for a true result based on a normal distribution) of the standard ratio. Most of the fortified product ratios in Table I are within 1 SD of the standard ratio, indicating an excellent correlation and clearly positive confirmation. Thus, confirmation can be easily achieved at an FQ concentration :!A0 ng/g. As noted earlier, confirmation was assisted by injection of 40 l.tL samples, rather than 20 1.tL, in order to produce a more intense MS signal. Optimum confirmation results are produced, particularly at low concentrations, by ensuring the atmospheric pressure ionizatin (API) stack of the instrument has been recently cleaned. As a test of this approach, chickens were dosed with ENRO for 3 days and then withdrawn from the drug. Samples of serum and muscle were taken (each time point representing the same pooled group of birds for the muscle and serum samples), extracted (with 5 replicate samples each), and analyzed throughout the dosing and withdrawal periods.
Average quantitative results for ENRO in the incurred samples are shown in Table 4 . The ENRO metabolite, CIP, was also detected in each analyzed sample of both serum and muscle, but in most cases the level was below the LOQ. It is interesting to note that ENRO can be successfully quantitated in both serum and muscle samples from the same birds using this method. While this work is not a pharmacokinetic study, ENRO levels appear to be consistently lower in serum than in muscle by approximately 2-3 times. It is clear, however, that ENRO can still be detected in serum of dosed chickens at least up to 48 h after withdrawal from the drug under these dosing conditions with this efficient and sensitive method.
Confirmation results from the incurred serum and muscle samples are shown in Table 5 . Average peak ratio values (5 replicate samples, each injected twice) are reported for both CIP and ENRO. Comparison with the average values for standard FQs in buffer over 6 analysis days shows excellent agreement. Higher RSD values for CIP peak ratios in serum samples towards the end of the withdrawal period reflect the lower CIP concentrations present.
Conclusions
This work demonstrates that serum can be successfully used as a matrix for analysis of FQ antibiotics in chicken, with the coupling of LC-fluorescence and MS to provide simultaneous quantitation and confirmation. Good recoveries from samples fortified with FQs over the range of 10-100 ng/g were obtained, with low LOQs and excellent RSDs. Confirmation of the FQs in these samples was allowed by comparison of MS peak ratios of the samples with those of standards. ENRO-incurred chicken serum and muscle samples were also successfully analyzed using this method. This work shows that ENRO and CIP can be detected and confirmed in both chicken serum and muscle at least up to 48 h after withdrawal from dosing with ENRO at a level that was formerly approved by the FDA. The ease of extraction of FQs from serum samples suggests this matrix as a promising alternative to monitoring for the presence of FQ residues in chicken.
